All these could be true for everyone new or old holders IF and...

First 3 Last

Share
Profile

Follow
Signbit

641 Posts.

85

10/12/19

14:12

Post #: 41890681
Share

Originally posted by Accumul8 ↑

Good little presentation which gives some clarity around where we are at currently.

I don't agree that it's fluff, they'll likely use it to start presenting to the market and for potential new investors, it's a great starting point to get the quick brief on the 2 projects.

We have confirmed we will be working on both concurrently, at the very least in the early stages.

Regarding the Kaolin project, we are awaiting drill permitting to start work on the twinning of selected holes and further drilling.

In relation to the Rare Earth project, we'll commence drilling at the start of the dry season and there will be plenty of work put into geological modelling etc in readiness for this. We can't drill any earlier due to the wet season.

All this and we've only just picked up the projects - what more do you want?

Again, I haven't been stung by whatever has happened in the past like longer-term holders believe they may have. But from my research, the last project was never really a goer they were really biding their time to find something worth pursuing. So that would bring with it poor communication, not a lot of positive newsflow etc.

I'm told it's all systems go with these two projects moving forward, so a big 2020 ahead. So far what I am seeing is in line with what the intentions of the company are. Pick up the phone and speak to the company to ease any concerns.

Now is the time to take your position for the newsflow ahead, IMO.

Expand

All these could be true for everyone new or old holders IF and only IF (at least for once) these mob could put shareholders before their mates... with those ridiculous CRs for $500K and time wasting 'never-really-a-goer' projects.

RMX Price at posting: 0.6¢ Sentiment: None Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 45 more messages in this thread...

First 3 Last

Add RMX (ASX) to my watchlist

(20min delay)
Last 0.1¢		Change 0.000(0.00%)		Mkt cap ! $3.873M

Open	High	Low	Value	Volume
0.1¢	0.1¢	0.1¢	$10	9.814K

All these could be true for everyone new or old holders IF and...

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Featured News

All these could be true for everyone new or old holders IF and...

Top Stories

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Featured News